GB0617602D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0617602D0
GB0617602D0 GBGB0617602.8A GB0617602A GB0617602D0 GB 0617602 D0 GB0617602 D0 GB 0617602D0 GB 0617602 A GB0617602 A GB 0617602A GB 0617602 D0 GB0617602 D0 GB 0617602D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0617602.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0617602.8A priority Critical patent/GB0617602D0/en
Publication of GB0617602D0 publication Critical patent/GB0617602D0/en
Priority to EP07803333.9A priority patent/EP2066344B2/en
Priority to BRPI0716519-6A2A priority patent/BRPI0716519A2/pt
Priority to EP12169665A priority patent/EP2491947A3/en
Priority to PCT/EP2007/059390 priority patent/WO2008028956A1/en
Priority to KR1020097007118A priority patent/KR20090057423A/ko
Priority to CA002662064A priority patent/CA2662064A1/en
Priority to SI200730635T priority patent/SI2066344T1/sl
Priority to CA002662051A priority patent/CA2662051A1/en
Priority to EA200900288A priority patent/EA015964B1/ru
Priority to AT07803333T priority patent/ATE511398T1/de
Priority to NZ575273A priority patent/NZ575273A/en
Priority to CNA2007800414575A priority patent/CN101534854A/zh
Priority to PL07803334T priority patent/PL2097102T3/pl
Priority to KR1020097007120A priority patent/KR20090058552A/ko
Priority to EA200900289A priority patent/EA016417B1/ru
Priority to UAA200901646A priority patent/UA95810C2/uk
Priority to EP07803334A priority patent/EP2097102B1/en
Priority to NZ575272A priority patent/NZ575272A/en
Priority to AU2007293673A priority patent/AU2007293673B2/en
Priority to DK07803333.9T priority patent/DK2066344T3/da
Priority to JP2009527147A priority patent/JP5814507B2/ja
Priority to CN200780041465.XA priority patent/CN101534855B/zh
Priority to BRPI0716518A priority patent/BRPI0716518B8/pt
Priority to PL07803333T priority patent/PL2066344T3/pl
Priority to CN201310079459.0A priority patent/CN103585624A/zh
Priority to SI200730990T priority patent/SI2097102T1/sl
Priority to UAA200901962A priority patent/UA97376C2/uk
Priority to ES07803334T priority patent/ES2387582T3/es
Priority to PT07803334T priority patent/PT2097102E/pt
Priority to ES07803333.9T priority patent/ES2365557T5/es
Priority to MX2009002560A priority patent/MX2009002560A/es
Priority to US12/440,054 priority patent/US8945582B2/en
Priority to US12/440,043 priority patent/US8956625B2/en
Priority to JP2009527148A priority patent/JP2010502679A/ja
Priority to MX2009002561A priority patent/MX2009002561A/es
Priority to PCT/EP2007/059391 priority patent/WO2008028957A2/en
Priority to AU2007293672A priority patent/AU2007293672B2/en
Priority to PT07803333T priority patent/PT2066344E/pt
Priority to CN201310235178XA priority patent/CN103357003A/zh
Priority to DK07803334.7T priority patent/DK2097102T3/da
Priority to NO20090865A priority patent/NO20090865L/no
Priority to IL197272A priority patent/IL197272A/en
Priority to IL197310A priority patent/IL197310A/en
Priority to NO20090897A priority patent/NO20090897L/no
Priority to ZA200901530A priority patent/ZA200901530B/xx
Priority to ZA200901592A priority patent/ZA200901592B/xx
Priority to CO09023296A priority patent/CO6160335A2/es
Priority to CO09023294A priority patent/CO6160334A2/es
Priority to MA31725A priority patent/MA30715B1/fr
Priority to CR10669A priority patent/CR10669A/es
Priority to MA31726A priority patent/MA30716B1/fr
Priority to CR10672A priority patent/CR10672A/es
Priority to HK09106864.1A priority patent/HK1129563A1/xx
Priority to HR20110431T priority patent/HRP20110431T1/hr
Priority to CY20111100621T priority patent/CY1111680T1/el
Priority to HRP20120557TT priority patent/HRP20120557T1/hr
Priority to CY20121100696T priority patent/CY1113419T1/el
Priority to JP2013149549A priority patent/JP2013256505A/ja
Priority to JP2014182142A priority patent/JP2015028041A/ja
Priority to US14/579,353 priority patent/US20150273047A1/en
Priority to JP2015158139A priority patent/JP2016020361A/ja
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0617602.8A 2006-09-07 2006-09-07 Vaccine Ceased GB0617602D0 (en)

Priority Applications (62)

Application Number Priority Date Filing Date Title
GBGB0617602.8A GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine
EP07803333.9A EP2066344B2 (en) 2006-09-07 2007-09-07 Inactivated Poliovirus combination vaccine
BRPI0716519-6A2A BRPI0716519A2 (pt) 2006-09-07 2007-09-07 Método para fabricar uma vacina
EP12169665A EP2491947A3 (en) 2006-09-07 2007-09-07 Vaccine
PCT/EP2007/059390 WO2008028956A1 (en) 2006-09-07 2007-09-07 Vaccine
KR1020097007118A KR20090057423A (ko) 2006-09-07 2007-09-07 백신
CA002662064A CA2662064A1 (en) 2006-09-07 2007-09-07 Method of producing a combination polivirus vaccine
SI200730635T SI2066344T1 (sl) 2006-09-07 2007-09-07 Inaktivirano poliovirusno kombinirano cepivo
CA002662051A CA2662051A1 (en) 2006-09-07 2007-09-07 Vaccine
EA200900288A EA015964B1 (ru) 2006-09-07 2007-09-07 Вакцина
AT07803333T ATE511398T1 (de) 2006-09-07 2007-09-07 Inaktiviertes poliovirus mischimpfstoff
NZ575273A NZ575273A (en) 2006-09-07 2007-09-07 Method for making combination vaccine comprising inactivated poliovirus type 1, diptheria toxoid and tetanus toxoid
CNA2007800414575A CN101534854A (zh) 2006-09-07 2007-09-07 疫苗
PL07803334T PL2097102T3 (pl) 2006-09-07 2007-09-07 Szczepionka skojarzona o zmniejszonej ilości antygenu wirusa polio
KR1020097007120A KR20090058552A (ko) 2006-09-07 2007-09-07 백신
EA200900289A EA016417B1 (ru) 2006-09-07 2007-09-07 Способ получения вакцины
UAA200901646A UA95810C2 (uk) 2006-09-07 2007-09-07 Інактивована поліовірусна вакцина
EP07803334A EP2097102B1 (en) 2006-09-07 2007-09-07 Combination vaccine having reduced polio virus antigen quantities
NZ575272A NZ575272A (en) 2006-09-07 2007-09-07 Inactivated poliovirus type 1, diptheria toxoid, tetanus toxoid and killed whole-cell Bordetella pertussis vaccine
AU2007293673A AU2007293673B2 (en) 2006-09-07 2007-09-07 Vaccine
DK07803333.9T DK2066344T3 (da) 2006-09-07 2007-09-07 Inaktiveret Poliovirus kombinationsvaccine
JP2009527147A JP5814507B2 (ja) 2006-09-07 2007-09-07 ワクチン
CN200780041465.XA CN101534855B (zh) 2006-09-07 2007-09-07 疫苗
BRPI0716518A BRPI0716518B8 (pt) 2006-09-07 2007-09-07 vacina de ipv e uso da mesma
PL07803333T PL2066344T3 (pl) 2006-09-07 2007-09-07 Skojarzona szczepionka zawierająca inaktywowany wirus polio
CN201310079459.0A CN103585624A (zh) 2006-09-07 2007-09-07 疫苗
SI200730990T SI2097102T1 (sl) 2006-09-07 2007-09-07 Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
UAA200901962A UA97376C2 (uk) 2006-09-07 2007-09-07 Вакцина
ES07803334T ES2387582T3 (es) 2006-09-07 2007-09-07 Vacuna de combinación con cantidades reducidas del antígeno del virus de la polio
PT07803334T PT2097102E (pt) 2006-09-07 2007-09-07 Vacina de combinação tendo quantidades reduzidas de antigénio de poliovírus
ES07803333.9T ES2365557T5 (es) 2006-09-07 2007-09-07 Vacunas de combinación de Poliovirus inactivado
MX2009002560A MX2009002560A (es) 2006-09-07 2007-09-07 Vacuna.
US12/440,054 US8945582B2 (en) 2006-09-07 2007-09-07 Vaccine
US12/440,043 US8956625B2 (en) 2006-09-07 2007-09-07 Inactivated polio vaccines
JP2009527148A JP2010502679A (ja) 2006-09-07 2007-09-07 ワクチン
MX2009002561A MX2009002561A (es) 2006-09-07 2007-09-07 Vacuna.
PCT/EP2007/059391 WO2008028957A2 (en) 2006-09-07 2007-09-07 Vaccine
AU2007293672A AU2007293672B2 (en) 2006-09-07 2007-09-07 Vaccine
PT07803333T PT2066344E (pt) 2006-09-07 2007-09-07 Vacina de combinação de poliovírus inactivado
CN201310235178XA CN103357003A (zh) 2006-09-07 2007-09-07 疫苗
DK07803334.7T DK2097102T3 (da) 2006-09-07 2007-09-07 Kombinationsvaccine med reducerede mængder af poliovirusantigen
NO20090865A NO20090865L (no) 2006-09-07 2009-02-25 Vaksine
IL197272A IL197272A (en) 2006-09-07 2009-02-26 IP vaccine used to vaccinate a human and its uses to prepare a cure for polio virus, clostridium tetani, corynebacterium diphtherla bordetella pertussis
IL197310A IL197310A (en) 2006-09-07 2009-02-26 A method for preparing a vaccine containing a polio virus that has been inactivated by type 1
NO20090897A NO20090897L (no) 2006-09-07 2009-02-26 Vaksine
ZA200901530A ZA200901530B (en) 2006-09-07 2009-03-03 Vaccine
ZA200901592A ZA200901592B (en) 2006-09-07 2009-03-05 Vaccine
CO09023296A CO6160335A2 (es) 2006-09-07 2009-03-06 Vacuna
CO09023294A CO6160334A2 (es) 2006-09-07 2009-03-06 Metodo para la elaboracion de una vacuna de conbinacion para proteger contra polio
MA31725A MA30715B1 (fr) 2006-09-07 2009-03-18 Vaccin
CR10669A CR10669A (es) 2006-09-07 2009-03-18 Vacuna
MA31726A MA30716B1 (fr) 2006-09-07 2009-03-18 Vaccin
CR10672A CR10672A (es) 2006-09-07 2009-03-19 Vacuna
HK09106864.1A HK1129563A1 (en) 2006-09-07 2009-07-24 Inactivated poliovirus combination vaccine
HR20110431T HRP20110431T1 (hr) 2006-09-07 2011-06-09 Kombinirano cjepivo od inaktiviranog poliovirusa
CY20111100621T CY1111680T1 (el) 2006-09-07 2011-06-28 Εμβολιο συνδυασμου απενεργοποιημενου ιου πολιομυελiτιδας
HRP20120557TT HRP20120557T1 (hr) 2006-09-07 2012-07-06 Kombinirano cjepivo sa smanjenim količinama antigena poliovirusa
CY20121100696T CY1113419T1 (el) 2006-09-07 2012-08-03 Εμβολιο συνδυασμου που εχει μειωμενες ποσοτητες αντιγονου ιου πολιομυελιτιδας
JP2013149549A JP2013256505A (ja) 2006-09-07 2013-07-18 ワクチン
JP2014182142A JP2015028041A (ja) 2006-09-07 2014-09-08 ワクチン
US14/579,353 US20150273047A1 (en) 2006-09-07 2014-12-22 Vaccine
JP2015158139A JP2016020361A (ja) 2006-09-07 2015-08-10 ワクチン

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617602.8A GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine

Publications (1)

Publication Number Publication Date
GB0617602D0 true GB0617602D0 (en) 2006-10-18

Family

ID=37232508

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0617602.8A Ceased GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine

Country Status (5)

Country Link
CN (2) CN101534855B (zh)
ES (1) ES2365557T5 (zh)
GB (1) GB0617602D0 (zh)
UA (2) UA95810C2 (zh)
ZA (2) ZA200901530B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945582B2 (en) 2006-09-07 2015-02-03 Glaxosmithkline Biologicals S.A. Vaccine

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112138155B (zh) * 2019-06-28 2022-04-12 怡道生物科技(苏州)有限公司 一种复合佐剂系统及制备该佐剂的方法
CN111467488B (zh) * 2020-04-17 2023-09-01 内蒙古必威安泰生物科技有限公司 一种水溶性复合免疫佐剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA40596C2 (uk) * 1992-05-23 2001-08-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини та спосіб її одержання
TR199802783T2 (xx) * 1996-07-02 1999-03-22 Connaught Laboratories Limited �ok de�erli DTP polyo a��lar.
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945582B2 (en) 2006-09-07 2015-02-03 Glaxosmithkline Biologicals S.A. Vaccine
US8956625B2 (en) 2006-09-07 2015-02-17 Glaxosmithkline Biologicals, S.A. Inactivated polio vaccines

Also Published As

Publication number Publication date
ZA200901592B (en) 2010-06-30
ES2365557T5 (es) 2016-12-07
ES2365557T3 (es) 2011-10-06
UA97376C2 (uk) 2012-02-10
CN101534855B (zh) 2017-08-01
CN101534855A (zh) 2009-09-16
UA95810C2 (uk) 2011-09-12
CN101534854A (zh) 2009-09-16
ZA200901530B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
GB0607088D0 (en) Vaccine
GB0717911D0 (en) Vaccine
GB0616306D0 (en) Vaccines
GB0700135D0 (en) Vaccine
GB0711858D0 (en) Vaccine
HK1129836A1 (zh) 疫苗
GB0710538D0 (en) Vaccine
GB0614460D0 (en) Vaccines
ZA200901592B (en) Vaccine
GB0625593D0 (en) Vaccine
GB0709373D0 (en) BCG-based anti-atheroma vaccine
GB0619826D0 (en) Vaccine
GB0620336D0 (en) Vaccine
GB0619824D0 (en) Vaccine
GB0619822D0 (en) Vaccine
GB0620337D0 (en) Vaccine
GB0620815D0 (en) Vaccine
GB0620816D0 (en) vaccine
GB0619821D0 (en) Vaccine
GB0619820D0 (en) Vaccine
GB0614476D0 (en) Vaccine
GB0614254D0 (en) Vaccine
GB0608962D0 (en) Vaccine
GB0607087D0 (en) Vaccine
GB0606256D0 (en) Anti-atheroma vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)